Abstract: A system and method of enabling row level security through security policies is disclosed herein. In this system and method, a computing device may be communicatively coupled to a storage device. The computing device may further be activated and maintain data that comprises a plurality of rows. When executed by the computing device, the system and method may process a data definition language statement comprising a security policy definition. Further, the system and method may receive a query language statement comprising a request to access a first column of a row from the plurality of rows. The system and method may process the request and determine if access may be granted to a user based on the security policy definition in the system.

Abstract: In one embodiment, an object in a database schema may be verified as having a valid digital signature associated with a trusted entity. An application may be permitted access to the object of the database schema only when the object of the database schema is verified to have a valid digital signature associated with the trusted entity. In another embodiment, an object in a database schema may be verified as having a digital signature associated with at least one trusted entity. An application may be permitted access to the object of the database schema only when the digital signature for the object is verified to be associated with the at least one trusted entity.

Abstract: The invention relates to percutaneous administration of drugs and vaccines in form of solid penetrating needles, “injectable needles”, comprising a polymeric matrix resulting from the polymerization of a polymerizable paste or mixture. The injectable needles are hard enough to penetrate the skin and can be administered percutaneously by simple pusher or injector delivery devices. The manufacturing procedure of the injectable needles allows for the incorporation of the drug as preformulated stable microparticles and incorporation of modifying agents to modulate stiffness, solubility and drug release. Drugs formulated in these injectable needles offer a safe, simple and effective alternative to conventional percutaneous drug delivery systems based on hypodermic needles and syringes that require refrigerated storage and reconstitution prior to administration.

Abstract: The invention relates to an oral pharmaceutical composition comprising the combination of an ibuprofen salt or S(+)-ibuprofen with L-arginine and/or the pharmaceutically acceptable salts thereof, and additionally pharmaceutically acceptable vehicles and/or excipients. The invention also relates to the method of producing the composition and to the use of said composition having synergic therapeutic activity, for treating moderate to severe inflammatory pain, fever and inflammation.

Abstract: A device for the remote tracking of water masses through a Global Positioning System (GPS) receiver equipped with a telecommunications modem and an electronic control board is provided. The device includes GPS locator enclosed within a floating watertight and sealed container or float. A method for the simultaneous management and operation of a set of one or more of such devices is also provided.

Abstract: The present embodiments relate generally to a free-floating device for the directional characterization of waves, comprising a selection of the following elements: sensors that can measure the earth's acceleration, angular velocity and magnetic field along three orthogonal axes, a GNSS tracker, an electronic module, a telecommunications module, energy capture and/or storage elements, a floating watertight container for housing the aforementioned equipment, having an optimized geometry so as to follow the slope of the surface of a water mass disturbed by waves. In addition, the information from the sensors and the GNSS tracker is managed by the electronic module and sent by the telecommunications module to a remote base station. Since the device is not anchored, it can characterize the direction of the surface waves more precisely, with improved operability and in a more economically efficient manner than current systems.

Abstract: In one embodiment, an object in a database schema may be verified as having a valid digital signature associated with a trusted entity. An application may be permitted access to the object of the database schema only when the object of the database schema is verified to have a valid digital signature associated with the trusted entity. In another embodiment, an object in a database schema may be verified as having a digital signature associated with at least one trusted entity. An application may be permitted access to the object of the database schema only when the digital signature for the object is verified to be associated with the at least one trusted entity.

Abstract: The present invention relates to a topical pharmaceutical composition that comprises the combination of an antimicrobial, a glucocorticoid, an antimycotic and pharmaceutically acceptable vehicles or excipients; the method for producing the composition and the use of said composition for treating localized dermatosis ailments.

Abstract: The present invention relates to a method for manufacturing a wind turbine blade in a production facility. The method comprises the steps of positioning a first overhung gantry to extend transversely over an elongated first mould part for manufacturing one of a first part and a second part of the blade, performing a first working action at the first mould part with a first tool mounted on the first overhung gantry, moving the first overhung gantry from the first mould part to an elongated second mould part for manufacturing the other of the first and the second part of the blade, positioning the first overhung gantry to extend transversely over the second mould part, and performing a second working action at the second mould part by means of the first tool or a second tool mounted on the first overhung gantry.

Abstract: An apparatus comprising elongated first and second moulds (2,3) extending in parallel, a drive mechanism (4) to move said second mould in relation to said first mould, from a first position to a second position so as to form a mould assembly, and a transport system comprising a movable part (5) movable along the first mould and/or the second mould and supported by an elongated intermediate support member (7) located between the moulds, the intermediate support member moving from a support position in which it supports the movable part, to a non-interference position in which interference with the moulds and/or the mould drive mechanism is avoided when said second mould is moved from the first position to the second position, the transport system comprising a securing device (71, 84, 83, 83a, 83b, 831, 83e) for locking the intermediate support member in the support position.

Abstract: In one embodiment, an object in a database schema may be verified as having a valid digital signature associated with a trusted entity. An application may be permitted access to the object of the database schema only when the object of the database schema is verified to have a valid digital signature associated with the trusted entity. In another embodiment, an object in a database schema may be verified as having a digital signature associated with at least one trusted entity. An application may be permitted access to the object of the database schema only when the digital signature for the object is verified to be associated with the at least one trusted entity.

Abstract: The present invention relates to a production facility (100, 200, 300, 400, 500) for forming elongated products, in particular wind turbine blades, wherein elongated mould assemblies (110a, 110b, 210a, 210b, 310a, 310b, 410a, 410b, 510a, 510b) may be accessed on the basis of an appropriate transport system (150, 250, 350, 450, 550) comprising at least one support member (251a-h, 151, 251, 351, 451, 551) laterally positioned between the elongated mould assemblies. The support member (251a-h, 151, 251, 351, 451, 551) is positioned so as to enable a rotational movement of an arm (121a, 121b, 221a) or is configured to change position or comprises a rotatable carrier element (259). For example, an elongated support member (151, 251, 351, 451, 551) may be positioned in a non-interference position, in which one or both mould assemblies can be moved into a position so as to form a composite mould assembly.

Abstract: A device for the remote tracking of water masses through a Global Positioning System (GPS) receiver equipped with a telecommunications modem and an electronic control board is provided. The device includes GPS locator enclosed within a floating watertight and sealed container or float. A method for the simultaneous management and operation of a set of one or more of such devices is also provided.

Abstract: The present invention relates to the pharmaceutical field, especially the field of combination and pharmaceutical compositions that comprise a lipase inhibitor and a phytoalexin and pharmaceutically acceptable vehicles or excipients; the present invention also relates to the method for manufacturing compositions containing the combination and the use of said composition in the treatment of conditions of excess weight, obesity and related health problems.

Abstract: The present invention incorporates new materials for bone regeneration, methods for their manufacture, and application in traumatology surgery, maxillofacial surgery, dental surgery, orthognatic surgery, endodontics, ophthalmology, neurosurgery and/or osteoporotic processes, and other indications where bone regeneration is required. In particular, the present invention incorporates synthetic materials with a 20% to a 95%, preferably between 40% and 90% in mass of monetite [Ca1-XMXHPO4, where 0?x?0.05, and where M can be a divalent metallic ion], and which in their final composition incorporate between 5% and 80%, preferably between 0% and 60%, in mass of bioactive calcium compounds chosen from calcium phosphates and between 5% and 80% in total mass of bioactive silicon compounds chosen from calcium silicates and/or bioactive silica glasses and gels.

Abstract: The invention relates to an oral pharmaceutical composition comprising the combination of an ibuprofen salt or S(+)-ibuprofen with L-arginine and/or the pharmaceutically acceptable salts thereof, and additionally pharmaceutically acceptable vehicles and/or excipients. The invention also relates to the method of producing the composition and to the use of said composition having synergic therapeutic activity, for treating moderate to severe inflammatory pain, fever and inflammation.

Abstract: Systems and methods that qualify and/or restrict access of codes associated with a database to objects located outside thereof and in other databases—even though a person executing such code does in fact have permission to interact with the object that the code is attempting to access. A sandbox component can regulate access from one database to another database, by managing authenticator permission and/or trust permission levels. Hence, the set of privileges assigned to security execution context of an executable module (procedure, trigger, computed column) in an un-trusted database is restricted not to exceed a privilege set assigned to database owner.

Abstract: The invention relates to percutaneous administration of drugs and vaccines in form of solid penetrating needles, “injectable needles”, comprising a polymeric matrix resulting from the polymerization of a polymerizable paste or mixture. The injectable needles are hard enough to penetrate the skin and can be administered percutaneously by simple pusher or injector delivery devices. The manufacturing procedure of the injectable needles allows for the incorporation of the drug as preformulated stable microparticles and incorporation of modifying agents to modulate stiffness, solubility and drug release. Drugs formulated in these injectable needles offer a safe, simple and effective alternative to conventional percutaneous drug delivery systems based on hypodermic needles and syringes that require refrigerated storage and reconstitution prior to administration.

Abstract: The present invention relates to a topical pharmaceutical composition that comprises the combination of an antimicrobial, a glucocorticoid, an antimycotic and pharmaceutically acceptable vehicles or excipients; the method for producing the composition and the use of said composition for treating localized dermatosis ailments.

Abstract: A modified-release oral pharmaceutical composition in capsules with microspheres contains loratadine, phenylephrine and pharmaceutically acceptable excipients. The composition has immediate bioavailability, with plasmatic concentration values within the therapeutic window with a uniform, continuous release. A method for the production of the composition and a method for treatment as a nasal decongestant and an antihistamine are included.